Replies to post #122 on Astex Pharmaceuticals (ASTX)

[surf1944]

6:17AM On The Wires (WIRES) Astex Pharmaceuticals (ASTX) has initiated a clinical trial with HSP90 inhibitor AT13387 in prostate cancer patients. The AT13387-04 study is a Phase 1-2, open label, randomized study in patients with castration-resistant prostate cancer who are no longer responding to treatment with standard of care therapies abiraterone acetate and steroids